Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

Add hypothesis: |

Complement-Mediated Synaptic Protection

C1QA · neurodegeneration · therapeutic

Composite
0.410

Price
$0.42

Evidence For
9

Evidence Against
3

## Complement-Mediated Synaptic Protection ### Mechanistic Hypothesis Overview The "Complement-Mediated Synaptic Protection" hypothesis proposes that excessive activation of the classical complement cascade — specifically the C1q-C3-C3aR and C4b pathways — drives synaptic loss in Alzheimer's disease by tagging synapses for microglial phagocytosis, and that complement pathway inhibition can preserve synapses and protect cognition. The central mechanistic claim is that Aβ oligomers and hyperphos

Complement C1q Suppression as Mechanism Linking Exercise Plasma to PV Interneuro

C1QA · neurodegeneration · combination

Composite
0.560

Price
$0.55

Evidence For
5

Evidence Against
4

# Complement C1q Suppression as Mechanism Linking Exercise Plasma to PV Interneuron Protection ## Introduction and Mechanistic Framework Parvalbumin (PV)-positive GABAergic interneurons constitute a critical subpopulation responsible for generating gamma-frequency oscillations (30-80 Hz), which are essential for hippocampal-cortical network synchronization and higher cognitive function. These interneurons are exceptionally vulnerable in multiple neurodegenerative conditions, including Alzheime

Verdict Summary

4/10

dimensions won

Complement-Mediated Synaptic Protection

6/10

dimensions won

Complement C1q Suppression as Mechanism

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic

0.60

0.78

Evidence

0.40

0.65

Novelty

0.60

0.70

Feasibility

0.50

0.40

Impact

0.70

0.80

Druggability

0.60

0.55

Safety

0.30

0.35

Competition

0.60

0.50

Data

0.50

0.45

Reproducible

0.50

0.60

Score Breakdown

Dimension	Complement-Mediated Synaptic P	Complement C1q Suppression as
Mechanistic	0.600	0.780
Evidence	0.400	0.650
Novelty	0.600	0.700
Feasibility	0.500	0.400
Impact	0.700	0.800
Druggability	0.600	0.550
Safety	0.300	0.350
Competition	0.600	0.500
Data	0.500	0.450
Reproducible	0.500	0.600

Evidence

Complement-Mediated Synaptic Protection

Supporting Evidence

Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neuro PMID:36600274 BMC Med 2023

Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's d PMID:36747024 Nat Neurosci 2023

Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. PMID:27114033 Cell 2016

The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modu PMID:39129007 J Neuroinflammation 2024

Synaptic pruning genes networks in Alzheimer's disease: correlations with neuropathology and cognitive decline. PMID:40515808 Geroscience 2026

Contradicting Evidence

Early complement genes are associated with visual system degeneration in multiple sclerosis. PMID:31289819

Single-cell RNA sequencing reveals distinct immunology profiles in human keloid. PMID:35990663

Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into disease pathophysiology. PMID:40972649

Complement C1q Suppression as Mechanism Linking Exercise Pla

Supporting Evidence

Young adult microglial deletion of C1q reduces engulfment of synapses and prevents cognitive impairment in aggressive AD PMID:41000995

SASP-Mediated Complement Cascade Amplification established as world model mechanism PMID:SASP_COMPLEMENT

Cognitive impairment in Alzheimer's disease facilitated by activated microglia via C1qA PMID:38266812

Complement-microglial axis drives synapse loss during memory impairment PMID:27337340

CR1 implicated in complement receptor in AD genetic risk loci PMID:AD_GENETIC_RISK_LOCI

Contradicting Evidence

C1q deletion prevents cognitive impairment in aggressive AD model uses developmental C1q deficiency, not acute adult mod PMID:41000995

No C1q-specific inhibitors in clinical development for any indication - all approved complement inhibitors target C5 or PMID:COMPLEMENT_LANDSCAPE

C1q has non-complement functions in synaptic homeostasis that may be disrupted by broad suppression PMID:NON_COMPLEMENT_FUNCTIONS

Debate Excerpts

Complement C1q Suppression as Mechanism Linking Ex

4 rounds · quality: 0.50

Theorist

# Novel Therapeutic Hypotheses for Exercise-Conditioned Plasma-Mediated Neuroprotection in POCD --- ## Hypothesis 1: FNDC5/Irisin as a Key Mediator of BDNF/TrkB Signaling Enhancement **Title:** M...

Skeptic

# Critical Evaluation of Exercise-Conditioned Plasma Neuroprotection Hypotheses in POCD I'll provide rigorous critiques of each hypothesis, identifying specific weaknesses, counter-evidence, altern...

Domain Expert

# Exercise-Conditioned Plasma Neuroprotection in POCD: Drug Development Reality Check ## Executive Assessment The field of exercise-conditioned plasma neuroprotection has generated compelling prec...

Synthesizer

```json { "ranked_hypotheses": [ { "rank": 1, "hypothesis_id": "H6", "title": "NMN Activates SIRT1 to Enhance Mitochondrial Biogenesis and Reduce Hippocampal Oxidative Stress...

Price History Overlay

Shared Evidence

No shared papers found across 5 total unique citations. These hypotheses draw from independent evidence bases.

Knowledge Graph Comparison

Complement-Mediated Synaptic Protection

107 edges

Top Node Types

gene66

hypothesis39

developmental_event1

biological_system1

Top Relations

co_associated_with34

targets25

associated_with_microglial_priming16

implicated_in14

associated_with9

Complement C1q Suppression as Mechanism

2 edges

Top Node Types

gene2

Top Relations

promoted: M1 Muscarinic Receptor Agonism as Pharmacological Exercise Substitute1

promoted: Complement C1q Suppression as Mechanism Linking Exercise Plasma to PV Interneuron Protection1

Pathway Diagrams

Curated mechanism pathway diagrams from expert analysis

Complement-Mediated Synaptic Protection

graph TD
    A["Amyloid beta oligomers"]
    B["Hyperphosphorylated tau"]
    C["C1QA gene expression"]
    D["C1q protein deposition"]
    E["Classical complement activation"]
    F["C3 convertase formation"]
    G["C3b opsonization"]
    H["C4b pathway activation"]
    I["Microglial CR3 receptors"]
    J["Synaptic phagocytosis"]
    K["Synaptic loss"]
    L["Cognitive decline"]
    M["Complement inhibitors"]
    N["C3aR antagonists"]
    O["Neuroprotective therapy"]

    A -->|"activates"| E
    B -->|"triggers"| E
    C -->|"upregulates"| D
    D -->|"initiates"| E
    E -->|"forms"| F
    F -->|"generates"| G
    E -->|"activates"| H
    G -->|"targets synapses"| I
    H -->|"enhances"| I
    I -->|"promotes"| J
    J -->|"causes"| K
    K -->|"leads to"| L
    M -->|"blocks"| E
    N -->|"inhibits"| I
    O -->|"prevents"| K

    classDef mechanism fill:#4fc3f7
    classDef pathology fill:#ef5350
    classDef therapy fill:#81c784
    classDef outcome fill:#ffd54f
    classDef genetics fill:#ce93d8

    class A,B,D,E,F,G,H mechanism
    class I,J,K,L pathology
    class M,N,O therapy
    class C genetics